The Treponema pallidum haemagglutination test (TPHA) was first described by Rathlev (1965) . The investigations made by Tomizawa and Kasamatsu (1966) and Tomizawa, Kasamatsu, and Yamaya (1969) , who introduced an absorbing reagent to remove cross-reacting antibodies, resulted in an improvement of this method and the production of standard antigen and other reagents necessary for the test. The reagents used by almost all these authors were manufactured in the Fuji Zoki Laboratories, Tokyo, Japan. The studies of Cox, Logan, and Norins (1969) led to the development of an automated microhaemagglutination assay (AMHA-TP).
The problem of specificity of the TPHA test cannot yet be regarded as finally solved. It would seem from the results of the investigations of Logan and Cox (1970) , Paris-Hamelin, Catalan, and Vaisman (1970) , Lesinski and Krach-Karczmarczyk (1971) , Dixon, Grocholski, and Kadis (1972) , Manikowska-Lesinska (1973a) , and Kraft, Morgenstern, Raff, and Soltz-Szots (1973) that the TPHA test approximates in specificity to the FTA-ABS test. The studies of West and Pagano (1972) , Garner, Backhouse, Daskalopoulos, and Walsh (1972) , Johnston (1972) , Kraft and others (1973) , Sequeira and Eldridge (1973), and O'Neill, Warner, and Nicol (1973) have established that the TPHA test is very rarely positive in presumed normal sera and relatively rarely in BFP reactors. The more recent investigations of Garner, Backhouse, Daskalopoulos, and Walsh (1973) , however, show that the specificity of the TPHA test can be considerably lower than that of the FTA-ABS test. They reported that 2 to 17 per cent. of TPI-negative leprosy sera and sera from selected groups of BFP reactors were also positive in the TPHA test. There is, on the whole, agreement in the results so far published regarding the sensitivity of the TPHA test. Logan and Cox (1970) , Le Clair (1971) , Received for publication January 7, 1974 Lesiiiski and Krach-Karczmarczyk (1973a) , O'Neill and others (1973) , and Johnston (1972) have estab- lished that the TPHA test is highly sensitive and, with the exception of early cases of primary syphilis, has a sensitivity practically equal to that of the FTA-ABS test. Only Luger and Spendlingwimmer (1973) have reported that its sensitivity is greater than that of the FTA-ABS test in all stages of syphilis.
The TPHA test has undeniable advantages in the comparative ease with which it is performed and read, and the fact that all the necessary reagents can be standardized, manufactured, and made available commercially. These advantages, together with the prospect of further automation of this method, will considerably facilitate its wide application. Dixon and others (1972) , O'Neill and others (1973) , Luger and Spendlingwimmer (1973) , and Sequeira and Eldridge (1973) consider it suitable as a qualitative screening test for syphilis and other treponematoses. Lesinski and Krach-Karczmarczyk (1971, 1973a,b) have shown that it is particularly valuable in the diagnosis of cases of late syphilis. The results of Manikowska-Lesinska (1973a,b) Sera from untreated syphilitics (270) 140 sera were from patients with early syphilis and 130 from patients with late syphilis. The large majority of late syphilitics, especially those with latent syphilis, were very long standing cases, detected serologically on hospital admission.
Sera from treated syphilitics (200) In this group there were 100 sera from patients treated for early syphilis, ninety from patients treated in the late stage of syphilis, and ten from persons followed up after prophylactic treatment given during the incubation period.
The patients treated for primary syphilis (predominantly VDRL-positive) were examined 12 to 18 months after treatment, those with secondary syphilis to 3 years after treatment and the patients with early latent syphilis, 3 years after treatment.
The patients with late syphilis were tested, at the earliest, 5 years after treatment, the majority being tested 10 to 30 years after treatment.
The patients who had received prophylactic treatment were tested 3 to 6 months after treatment. At the beginning of this treatment all these patients had no clinical signs of syphilis and were FTA-ABS and VDRL negative. All the persons admitted that they had had sexual relations with a person suffering from early syphilis not less than 4 weeks before beginning prophylactic treatment.
Problem sera (200) This group consisted of 200 sera with disagreement between the TPI and FTA-ABS results or with doubtful TPI or borderline FTA-ABS results.
Methods
The TPHA test was carried out on the first 100 patients with standard antigens according to the macro-method described by Tomizawa and Kasamatsu (1966) . The remaining sera were tested by the manual micro-method, based on the modification of Cox and others (1969) . The reagents used in both TPHA modifications were manufactured in the Fuji Zoki Laboratories. The results of both these methods were practically identical. The sera were tested at a dilution of 1/80. Some of the doubtful results or those difficult to interpret were repeated at a dilution of 1/40 or 1/160. TPI, VDRL, FTA, and FTA-ABS tests were carried out according to the description in the Polish manual "Modern Syphilology" (edited by Lesiniski, Miedzinski, and Towpik (1970) . These methods differ only slightly from the methods described in the USPHS "Manual of Tests for Syphilis" (1964 Syphilis" ( , 1969 (Table I) Of the 600 probably healthy persons, a positive or doubtful TPHA result was obtained in six. There was nothing in the clinical findings or history to indicate syphilis in four of these cases (0-66 per cent. of the total investigated). One teacher and one hospitalized patient who were each found to have positive TPHA and negative TPI and reagin test results, were noted in our files as having been treated for syphilis 25 and 18 years before respectively. Three of these five gave doubtful TPHA results and the remaining two were strongly positive. In two other cases with positive TPHA and reagin tests but negative TPI tests, epidemiological evidence and repeat FTA-ABS tests revealed that the patients had previously been infected with syphilis. Among 51 sera which were TPI non-reactive and gave a weak fluorescence of the borderline type making it particularly difficult to interpret the specificity of the FTA-ABS results, the TPHA test was positive in forty. In 32 sera with positive TPHA results, reagin antibodies were also found. The demonstration of three types of antibody (Logan and Cox, 1970; West and Pagano, 1972; O'Neill and others, 1973) The results obtained from the group of 600 sera from persons without any symptoms and probably free from syphilitic infection seem to confirm the views of Luger and Spendlingwimmer (1973) , West and Pagano (1972) , Johnston (1972) , O'Neill and others (1973) With further automation of the method and a reduction in the cost of producing the antigen, the 470 serums provenaient de sujets syphilitiques, 600 de sujets pr6sumes sains et 130 de sujets presum6s faussement positifs (BFP) et 200 posaient des problemes serologiques parmi lesquels la majorite montrait une discordance entre les resultats du FTA-ABS et du TPI.
Ces recherches montrerent que, au stade primaire de la syphilis, la sensibilite du TPHA est moindre que celle du FTA-ABS mais legerement plus grande que celle du VDRL. Au stade secondaire de la syphilis, la sensibilite fut equivalente a celle de l'epreuve FTA-ABS. Au stade tardif de la syphilis, il fut note une tres petite tendance du TPHA au retour spontane a la negativite et sa sensibilite n'est pas seulement beaucoup plus elev6e que celle du TPI mais egalement plus elevee que celle du FTA-ABS.
Dans les cas de syphilis primaire ou secondaire traites, on observe rarement le retour a la negativite du TPHA; ceci survint beaucoup moins fr6quemment qu'avec le TPI et un peu moins souvent qu'avec le FTA-ABS. Dans les cas de syphilis tradive traites, le TPHA resta generalement fortement positif.
Laspecificite duTPHAn'est pas absolue mais correspond a celle du FTA-ABS. La question de la possibilite de resultats non sp6cifiques dans certains groupes de reacteurs BFP n'a pas, jusqu'ici, e resolue d'une maniere satisfaisant.
Une analyse des resultats de ces epreuves serologiques ainsi que de 1'ensemble des preuves cliniques et epidemiologiques dans le groupe des serums posant des problemes a montre que 1'epreuve TPHA est un critere important, aussi bien pour 1'etude des serums posant des problemes que pour le diagnostic des cas de syphilis tardive. Ce test a une valeur particuliere lorsqu'il y a desaccord entre les resultats du TPI et de 1'epreuve FTA-ABS.
Avec I'automation ulterieure de la m6thode, et avec une diminution du cofit de production de l'antigene, 1'epreuve TPHA pourra bien remplacer les epreuves de reagine dans les dispositifs de depistage.
